Pharmaceutical Executive Daily: Pharm Exec Ranks Top 50 Companies of 2026

Aug 14, 05:09 PM
Headliner
Share
Subscribe

Pharmaceutical Executive releases its 2026 Top 50 company rankings, FDA grants Bristol Myers Squibb's Zenbexus accelerated approval for multiple myeloma, and PwC's Glenn Hunzinger talks the shifting economics of pharma dealmaking.

Share
Subscribe
Next
Pharmaceutical Executive Daily: 2026 Emerging Pharma Leaders Award Winners Announced
Top episodes
Healthcare Marketing Strategies for Reaching Diverse Audiences
by Pharmaceutical Executive
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
by Pharmaceutical Executive
Key Findings of the NIAGARA and HIMALAYA Trials
by Pharmaceutical Executive